- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/22 - Benzenesulfonamido pyrazines
Patent holdings for IPC class C07D 241/22
Total number of patents in this class: 23
10-year publication summary
|
1
|
2
|
2
|
3
|
1
|
1
|
1
|
2
|
0
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ChemoCentryx, Inc. | 378 |
4 |
| Vertex Pharmaceuticals Incorporated | 1626 |
2 |
| Genzyme Corporation | 1303 |
2 |
| Sanford-Burnham Medical Research Institute | 126 |
2 |
| The Regents of the University of California | 20211 |
1 |
| AstraZeneca AB | 2853 |
1 |
| Takeda Pharmaceutical Company Limited | 2713 |
1 |
| J.B. Chemicals & Pharmaceuticals Limited | 2 |
1 |
| Kyowa Hakko Kirin Co., Ltd. | 280 |
1 |
| Merck Serono S.A. Geneva | 1 |
1 |
| New York Blood Center, Inc. | 167 |
1 |
| Pfizer Limited | 177 |
1 |
| Sanford Burnham Prebys Medical Discovery Institute | 303 |
1 |
| UChicago Argonne, LLC | 930 |
1 |
| Rheinisch Westfälische Technische Hochschule Aachen (rwth) | 30 |
1 |
| Jiangsu Yingkebeita Yiyaokeji Co. Ltd. | 1 |
1 |
| Shanghai Yidi Biotechnology Co., Ltd. | 7 |
1 |
| Other owners | 0 |